BEIHAI BIOTECH
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99216559
- Mark type
- Design + words
- Filed
- 03 Jun 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Charles Ho
Goods and services
- Class 005 — Pharmaceuticals: Analgesics; Antiemetics; Biological preparations for the treatment of cancer; Blood substitute for human use; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer; Medicinal infusions for treating cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the treatment of cancer; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical reagents for medical purposes
Owner
- Zhuhai Beihai Biotech Co., Ltd., Zhuhai, Guangdong, CN
- Zhuhai Beihai Biotech Co., Ltd., Zhuhai, Guangdong, CN
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Feb 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 05 Jan 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 05 Jan 2026 — FINAL REFUSAL E-MAILED
- 05 Jan 2026 — FINAL REFUSAL WRITTEN
- 05 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Nov 2025 — NON-FINAL ACTION E-MAILED